Registered number
07591817
Biofresh Group Limited
Unaudited Accounts
31 December 2024
Biofresh Group Limited
Registered number: 07591817
Balance Sheet
as at 31 December 2024
Notes 2024 2023
£ £
Fixed assets
Investments 3 - 342,254
Current assets
Stocks 215,762 239,502
Debtors 4 41,539 87,531
Cash at bank and in hand 2,408 43
259,709 327,076
Creditors: amounts falling due within one year 5 (1,257,058) (1,209,029)
Net current liabilities (997,349) (881,953)
Total assets less current liabilities (997,349) (539,699)
Creditors: amounts falling due after more than one year 6 (75,614) (127,424)
Net liabilities (1,072,963) (667,123)
Capital and reserves
Called up share capital 1,332 1,332
Profit and loss account (1,074,295) (668,455)
Shareholders' funds (1,072,963) (667,123)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
J Caisley
Director
Approved by the board on 31 December 2025
Biofresh Group Limited
Notes to the Accounts
for the year ended 31 December 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going Concern
The accounts have been prepared on a going concern basis. The company is reliant upon the support of the directors, and of Japan Concept Limited (a company under the control of Mr Jonathan Caisley, a director), to enable day to day working capital requirements to be met. The directors are confident that this will be sufficient to allow the company to meet its obligations as they fall due for at least 12 months from the balance sheet date and, on this basis, consider it appropriate to prepare financial statements on a going concern basis. The financial statements do not include any adjustments that would result if the directors withdrew their support.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 2
3 Investments
Investments in
subsidiary
undertakings
£
Cost
At 1 January 2024 342,254
Revaluation (342,254)
At 31 December 2024 -
Historical cost
At 1 January 2024 342,074
At 31 December 2024 342,074
The following were subsidiary undertakings of the company:
Ozone Direct (UK) Limited - Registered office: Unit 3, Bearl, Stocksfield, Northumberland, United Kingdom, NE43 7AL. The company was dissolved on 9th July 2024 with no return to shareholders.
Biofresh Europa Srl - Registered office: Via Angelo Musco 8, 25129 Brescia (BS) Italy. Winding up of the company commenced in September 2025 and will be finalised on 31st December 2025 with no return to shareholders anticipated.
The company owns 100% of the ordinary share capital in each of its subsidiary undertakings.
The directors are satisfied that the company is entitled to exemption from the requirement to prepare group accounts under section 399(SA) of the Companies Act 2006.
4 Debtors 2024 2023
£ £
Trade debtors 39,162 43,418
Other debtors 2,377 44,113
41,539 87,531
5 Creditors: amounts falling due within one year 2024 2023
£ £
Bank loans and overdrafts 79,364 71,652
Trade creditors 41,258 30,252
Other creditors 1,136,436 1,107,125
1,257,058 1,209,029
6 Creditors: amounts falling due after one year 2024 2023
£ £
Bank loans 75,614 127,424
7 Events after the reporting date
In January 2025 the company made an offer of £100,000 to be paid to a former employee in respect to compensation for an injury sustained at work. The company is awaiting the results of a claim made to The Financial Ombudsman Service for compensation from the company's insurers in respect to advice received relating to this matter.
8 Related party transactions
During the year, the company received loans from members of key management personnel. The loans are repayable on demand and the rate of interest charged is 0%. At the balance sheet date £20,565 was still outstanding (2023: £12,029) and is presented within creditors: amounts falling due within one year.
During the year, the company received loans from a company under the control of a key member of management personnel. The loan is repayable on demand and the rate of interest charged is 0%. At the balance sheet date £1,113,663 was still outstanding (2023: £1,082,091) and is presented within creditors: amounts falling due within one year.
During the year, the company provided administrative and technical support to its subsidiary, Biofresh Europa Srl. Charges relating to these services totalling £Nil (2023:£12,048) were raised during the year. £nil (2023: £33,544) was outstanding at the balance sheet date and was included within other debtors.
9 Controlling party
The company is under the control of the directors.
10 Other information
Biofresh Group Limited is a private company limited by shares and incorporated in England. Its registered office is:
Unit 3, Bearl
Stocksfield
Northumberland
NE43 7AL
Biofresh Group Limited 07591817 false 2024-01-01 2024-12-31 2024-12-31 VT Final Accounts April 2025 J Caisley No description of principal activity 07591817 2023-01-01 2023-12-31 07591817 core:WithinOneYear 2023-12-31 07591817 core:AfterOneYear 2023-12-31 07591817 core:ShareCapital 2023-12-31 07591817 core:RetainedEarningsAccumulatedLosses 2023-12-31 07591817 2024-01-01 2024-12-31 07591817 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07591817 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 07591817 bus:Director40 2024-01-01 2024-12-31 07591817 1 2024-01-01 2024-12-31 07591817 countries:England 2024-01-01 2024-12-31 07591817 bus:FRS102 2024-01-01 2024-12-31 07591817 bus:FilletedAccounts 2024-01-01 2024-12-31 07591817 2024-12-31 07591817 core:WithinOneYear 2024-12-31 07591817 core:AfterOneYear 2024-12-31 07591817 core:ShareCapital 2024-12-31 07591817 core:RetainedEarningsAccumulatedLosses 2024-12-31 07591817 core:RevaluationsIncreaseDecreaseInInvestments 2024-12-31 07591817 2023-12-31 iso4217:GBP xbrli:pure